Cargando…
Editorial note: repurposing FDA approved drugs as FXR agonists: a structure based in silico pharmacological study
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
Portland Press Ltd.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9400029/ https://www.ncbi.nlm.nih.gov/pubmed/35994294 http://dx.doi.org/10.1042/BSR-2021-2791_EDN |
| _version_ | 1784772660985593856 |
|---|---|
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9400029 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Portland Press Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-94000292022-09-06 Editorial note: repurposing FDA approved drugs as FXR agonists: a structure based in silico pharmacological study Biosci Rep Editorial Note Portland Press Ltd. 2022-08-22 /pmc/articles/PMC9400029/ /pubmed/35994294 http://dx.doi.org/10.1042/BSR-2021-2791_EDN Text en © 2022 The Author(s). https://creativecommons.org/licenses/by/4.0/This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution License 4.0 (CC BY) (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Editorial Note Editorial note: repurposing FDA approved drugs as FXR agonists: a structure based in silico pharmacological study |
| title | Editorial note: repurposing FDA approved drugs as FXR agonists: a structure based in silico pharmacological study |
| title_full | Editorial note: repurposing FDA approved drugs as FXR agonists: a structure based in silico pharmacological study |
| title_fullStr | Editorial note: repurposing FDA approved drugs as FXR agonists: a structure based in silico pharmacological study |
| title_full_unstemmed | Editorial note: repurposing FDA approved drugs as FXR agonists: a structure based in silico pharmacological study |
| title_short | Editorial note: repurposing FDA approved drugs as FXR agonists: a structure based in silico pharmacological study |
| title_sort | editorial note: repurposing fda approved drugs as fxr agonists: a structure based in silico pharmacological study |
| topic | Editorial Note |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9400029/ https://www.ncbi.nlm.nih.gov/pubmed/35994294 http://dx.doi.org/10.1042/BSR-2021-2791_EDN |